{"id":446709,"title":"Notice of Consultation on the Prescription Drug List (PDL): Metamizole (dipyrone)  - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-03","captureTimestamp":"2026-01-03T12:38:44.914000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/consultation-metamizole-dipyrone.html?wbdisable=false","snippet":"Notice of Consultation on the Prescription Drug List (PDL): Metamizole (dipyrone) April 23, 2021 Our file number: 21-107779-356 This Notice of Consultation provides an opportunity to comment on the proposal to add metamizole (also known as ‘dipyrone’) to the Prescription Drug…","rawSnapshotUrl":"/api/snapshots/raw/446709","browseUrl":"https://replay.healtharchive.ca/job-6/20260103123844/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/consultation-metamizole-dipyrone.html?wbdisable=false#ha_snapshot=446709","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}